Lorfenamin


Indications and Reactions:

Role Indications Reactions
Secondary
Hepatitis C 15.5%
Product Used For Unknown Indication 13.6%
Prophylaxis 11.7%
Influenza 10.7%
Chronic Hepatitis C 5.8%
Herpes Zoster 5.8%
Gastritis 4.9%
Hypertension 4.9%
Pyrexia 4.9%
Dementia With Lewy Bodies 3.9%
Rash 3.9%
Cancer Pain 1.9%
Cerebral Infarction 1.9%
Constipation 1.9%
Menopause 1.9%
Nausea 1.9%
Precursor T-lymphoblastic Lymphoma/leukaemia Stage I 1.9%
Antifungal Prophylaxis 1.0%
Epilepsy 1.0%
Gastritis Prophylaxis 1.0%
Blood Creatinine Increased 23.5%
Pneumonitis 17.6%
Toxic Skin Eruption 17.6%
Hepatic Function Abnormal 11.8%
Stevens-johnson Syndrome 11.8%
Gastritis 5.9%
Oedema 5.9%
Tubulointerstitial Nephritis 5.9%
Concomitant
Rheumatoid Arthritis 17.8%
Prophylaxis 14.8%
Product Used For Unknown Indication 9.5%
Hepatitis C 9.4%
Chronic Hepatitis C 6.4%
Plasma Cell Myeloma 6.2%
Colorectal Cancer 6.0%
Upper Respiratory Tract Inflammation 4.7%
Hypertension 4.2%
Drug Use For Unknown Indication 3.2%
Multiple Myeloma 2.6%
Hepatic Neoplasm Malignant 2.5%
Lung Adenocarcinoma Metastatic 2.5%
Diarrhoea 2.0%
Insomnia 1.8%
Hyperlipidaemia 1.5%
Cancer Pain 1.4%
Back Pain 1.3%
Gastritis 1.3%
Pyrexia 1.3%
White Blood Cell Count Decreased 12.9%
Rash 11.3%
Platelet Count Decreased 8.1%
Interstitial Lung Disease 6.5%
International Normalised Ratio Increased 5.6%
Stomatitis 5.6%
Vomiting 5.6%
Anaemia 4.0%
Hepatic Function Abnormal 4.0%
Sepsis 4.0%
Acute Respiratory Distress Syndrome 3.2%
Anaphylactic Shock 3.2%
Decreased Appetite 3.2%
Erythema Multiforme 3.2%
Lung Disorder 3.2%
Oedema Peripheral 3.2%
Renal Cell Carcinoma 3.2%
Renal Impairment 3.2%
Respiratory Failure 3.2%
Thrombocytopenia 3.2%

Drug Data